KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ugi (UGI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Ugi (UGI) over the last 17 years, with Q4 2025 value amounting to $251.0 million.

  • Ugi's Cash & Equivalents rose 458.33% to $251.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $251.0 million, marking a year-over-year increase of 458.33%. This contributed to the annual value of $335.0 million for FY2025, which is 5727.7% up from last year.
  • Latest data reveals that Ugi reported Cash & Equivalents of $251.0 million as of Q4 2025, which was up 458.33% from $335.0 million recorded in Q3 2025.
  • Over the past 5 years, Ugi's Cash & Equivalents peaked at $855.0 million during Q3 2021, and registered a low of $183.0 million during Q2 2024.
  • In the last 5 years, Ugi's Cash & Equivalents had a median value of $327.5 million in 2021 and averaged $378.8 million.
  • In the last 5 years, Ugi's Cash & Equivalents skyrocketed by 15446.43% in 2021 and then tumbled by 6119.4% in 2023.
  • Quarter analysis of 5 years shows Ugi's Cash & Equivalents stood at $334.0 million in 2021, then fell by 5.09% to $317.0 million in 2022, then plummeted by 35.65% to $204.0 million in 2023, then rose by 17.65% to $240.0 million in 2024, then rose by 4.58% to $251.0 million in 2025.
  • Its Cash & Equivalents stands at $251.0 million for Q4 2025, versus $335.0 million for Q3 2025 and $350.0 million for Q2 2025.